Schroeder Mark S's Form 4 filing
Labcorp Holdings Inc. (LH) · filed Apr 3, 2023
- Accession no.
- 0001127602-23-011746
- Filed
- Apr 3, 2023
- Trade date
- Mar 30-31, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $880.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder Mark SCIK 0001793112 | Officer (EVP, President-Diagnostics Lab) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 | Common Stock | AGrant or awardAcquired | +6,763 | $0.00 | $0 | 13,450.4 | Direct | |
| Mar 30, 2023 | Common Stock | FTax withholdingDisposed | −2,866 | $224.70 | −$643,990.2 | 10,584.4 | Direct | |
| Mar 31, 2023 | Common Stock | SSaleDisposed | −3,897 | $225.81 | −$879,981.57 | 6,687.4 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.